Navigation Links
AdvaMed Releases New Survey Results on DTC Campaigns
Date:10/14/2009

WASHINGTON, Oct. 14 /PRNewswire-USNewswire/ -- The Advanced Medical Technology Association (AdvaMed), the leading trade association representing America's medical technology companies, today released results from a snapshot survey with Porter Novelli about direct-to-consumer (DTC) marketing initiatives, during a panel discussion on the topic at the third annual AdvaMed 2009 conference.

The goal of the survey is to assess how medical device companies are conducting DTC marketing initiatives. Of survey respondents, an overwhelming majority of DTC marketing campaigns, 94 percent, are focused on patient benefit materials, such as patient educational brochures, with the majority of existing advertising campaigns coming from print advertising. Although more traditional media outlets still constitute the majority of activities, the survey results reveal social media is still a fairly new phenomenon in comparison to existing DTC marketing campaigns.

The panel highlighted the importance of using DTC marketing campaigns to encourage discussion between patients and healthcare professionals and the need to clearly communicate the consumer risks and benefits of medical technology. Attendees also heard how to incorporate the new AdvaMed DTC advertising guiding principles into successful consumer awareness campaigns.

"DTC marketing and advertising can be particularly helpful in raising awareness of new lifesaving and life-enhancing technologies and underutilized medical technology," said Tony Blank, participating panelist, and vice president, cardiovascular regulatory affairs, Boston Scientific Corporation. "Industry is committed to supporting responsible DTC advertising and AdvaMed's guiding principles when developing campaigns to ensure both benefit and risk information is presented to patients in a clear and understandable manner."

"When direct-to-consumer marketing enhances the public health, that's smart and savvy communications," said Peter Pitts, participating panelist, and partner and director, global health, Porter Novelli.

Designed by industry and for industry, AdvaMed 2009 is the premier MedTech conference for CEOs, business executives, policy-makers, members of the media, financiers, and service providers and other MedTech leaders from around the world. In only its second year, AdvaMed 2008 attracted 1,400 industry leaders including 500+ CEOs, Presidents and C-Level executives.

AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. Our members produce nearly 90 percent of the health care technology purchased annually in the United States and more than 50 percent purchased annually around the world. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit www.advamed.org.

SOURCE AdvaMed and AdvaMed 2009


'/>"/>
SOURCE AdvaMed and AdvaMed 2009
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Vibrant Exhibit Hall Features Innovative Medical Technology at AdvaMed 2009
2. Medical Technology Executives Descend on D.C. as AdvaMed 2009: The MedTech Conference Kicks Off and Health Care Debate Continues
3. Adnavance Technologies to Present Initial Data Supporting Direct Detection Molecular Diagnostic Tests at AdvaMed 2009 and BIOCOM Investor Conference
4. CEL-SCI Corporation Releases Letter to Shareholders
5. Regado Biosciences Releases Positive Phase 2a Data for the Reversible Anticoagulant System REG1 at the European Society of Cardiology Congress In Barcelona, Spain
6. Velos, Inc. Releases Software to Support Cancer Centers With New Workflow and Content for NCI Clinical Trials Reporting Program
7. CEL-SCI Corporation Releases Letter to Shareholders
8. CEL-SCI Corporation Releases Letter to Shareholders
9. Inclinix Releases Next Generation Critical Population Research(R) (CPR) for Clinical Trial Investigator Site Selection and Patient Recruitment
10. Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials
11. Eularis Releases First-Ever Study on ROI of Pre-Launch Named Patient Programmes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, ... M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... the most handsome men, look naturally attractive. Plastic surgery should be invisible.” He ...
Breaking Medicine News(10 mins):